Hrt Financial LP Surmodics Inc Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.44 - $35.56 $50,187 - $65,039	-1,829 Reduced 5.97%	28,821 $845,000
Q4 2023 Feb 09, 2024	SELL	$28.47 - $38.49 $103,346 - $139,718	-3,630 Reduced 10.59%	30,650 $1.11 Million
Q3 2023 Nov 13, 2023	BUY	$28.28 - $38.36 $89,166 - $120,949	3,153 Added 10.13%	34,280 $1.1 Million
Q2 2023 Aug 11, 2023	SELL	$17.67 - $31.31 $314,101 - $556,566	-17,776 Reduced 36.35%	31,127 $974,000
Q1 2023 May 12, 2023	BUY	$17.13 - $38.52 $837,708 - $1.88 Million	48,903 New	48,903 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $287,562 - $383,328	-6,655 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $149,635 - $170,946	2,834 Added 74.17%	6,655 $370,000
Q2 2021 Aug 16, 2021	BUY	$51.29 - $59.15 $195,979 - $226,012	3,821 New	3,821 $207,000

126

12M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.